open access

Vol 12, No 4 (2017)
Original Papers
Published online: 2017-09-19
Get Citation

Atrial fibrillation in patients with ischemic stroke - clinical characteristics and in-hospital prognosis - pilot study.

Justyna Tracz, Iwona Gorczyca-Michta, Konrad Jarząbek, Ewa Kołodziejska, Anita Rosołowska, Beata Wożakowska-Kapłon
DOI: 10.5603/FC.2017.0066
·
Folia Cardiologica 2017;12(4):344-348.

open access

Vol 12, No 4 (2017)
Original Papers
Published online: 2017-09-19

Abstract

Introduction Thromboembolic complications are the most serious consequences of atrial fibrillation (MP). Atrial fibrillation significantly worsens prognosis in patients with ischemic stroke. The aim of the study was to evaluate the prevalence of MP in hospitalized patients due to ischemic stroke, the assessment of the incidence of co-morbidities and the evaluation of in-hospital prognosis in the study group.

Methodology The retrospective study enrolled 2000 patients with cerebral stroke hospitalized in the years 2013-2014. The ischemic stroke was diagnosed on the basis of the patient's clinical picture and head imaging (TK or MRI head).

Results In the whole study group (n = 2000), 579 patients (28.5%) had MP, MP (+), and 456 patients (78.8%) had arrhythmia prior to admission. The hospital, and 123 (21.2%) patients were first detected MP. The mean age of patients in the MP (+) group was 78.6 years, and in the MP group (-) 71.6 years. Carotid artery ultrasonography was performed in 1805 patients with ischemic stroke. This study demonstrated critical vasoconstriction (> 70%) in 232 patients (16.3%) in the MP (+) group and in 69 (11.9%) patients in the MP (-) group. Significant neurological deficit (> 10 points) at hospital admission was observed in 485 patients (34.2%) in the MP group (-) and 196 patients (33.85%) in the MP (+) group. At discharge from the hospital, 224 (15.7%) without MP had a significant neurological deficit or functional impairment, and in the MP (+) group it was 226 (39.03%). 229 patients (16.1%) without MP and 22 subjects (15.5%) with MP died during hospitalization.

Conclusions Atrial fibrillation was often found in arrhythmia in patients with ischemic stroke. Patients with stroke and MP were older than patients with stroke and sinus rhythm. Critical stenosis of the carotid arteries was found in a higher proportion of patients with arrhythmia than sinus rhythm.

331/5000

Deterioration of the neurological deficit during hospitalization was reported in a higher proportion of patients with MP than without arrhythmias. In-hospital mortality in stroke patients was similar in patients with MP and in patients with sinus rhythm.

Abstract

Introduction Thromboembolic complications are the most serious consequences of atrial fibrillation (MP). Atrial fibrillation significantly worsens prognosis in patients with ischemic stroke. The aim of the study was to evaluate the prevalence of MP in hospitalized patients due to ischemic stroke, the assessment of the incidence of co-morbidities and the evaluation of in-hospital prognosis in the study group.

Methodology The retrospective study enrolled 2000 patients with cerebral stroke hospitalized in the years 2013-2014. The ischemic stroke was diagnosed on the basis of the patient's clinical picture and head imaging (TK or MRI head).

Results In the whole study group (n = 2000), 579 patients (28.5%) had MP, MP (+), and 456 patients (78.8%) had arrhythmia prior to admission. The hospital, and 123 (21.2%) patients were first detected MP. The mean age of patients in the MP (+) group was 78.6 years, and in the MP group (-) 71.6 years. Carotid artery ultrasonography was performed in 1805 patients with ischemic stroke. This study demonstrated critical vasoconstriction (> 70%) in 232 patients (16.3%) in the MP (+) group and in 69 (11.9%) patients in the MP (-) group. Significant neurological deficit (> 10 points) at hospital admission was observed in 485 patients (34.2%) in the MP group (-) and 196 patients (33.85%) in the MP (+) group. At discharge from the hospital, 224 (15.7%) without MP had a significant neurological deficit or functional impairment, and in the MP (+) group it was 226 (39.03%). 229 patients (16.1%) without MP and 22 subjects (15.5%) with MP died during hospitalization.

Conclusions Atrial fibrillation was often found in arrhythmia in patients with ischemic stroke. Patients with stroke and MP were older than patients with stroke and sinus rhythm. Critical stenosis of the carotid arteries was found in a higher proportion of patients with arrhythmia than sinus rhythm.

331/5000

Deterioration of the neurological deficit during hospitalization was reported in a higher proportion of patients with MP than without arrhythmias. In-hospital mortality in stroke patients was similar in patients with MP and in patients with sinus rhythm.

Get Citation

Keywords

ischemic stroke; atrial fibrillation,; thromboembolic complications

About this article
Title

Atrial fibrillation in patients with ischemic stroke - clinical characteristics and in-hospital prognosis - pilot study.

Journal

Folia Cardiologica

Issue

Vol 12, No 4 (2017)

Pages

344-348

Published online

2017-09-19

DOI

10.5603/FC.2017.0066

Bibliographic record

Folia Cardiologica 2017;12(4):344-348.

Keywords

ischemic stroke
atrial fibrillation

thromboembolic complications

Authors

Justyna Tracz
Iwona Gorczyca-Michta
Konrad Jarząbek
Ewa Kołodziejska
Anita Rosołowska
Beata Wożakowska-Kapłon

References (19)
  1. Abu-Assi E, Otero-Raviña F, Allut Vidal G, et al. Grupo Barbanza researchers. Comparison of the reliability and validity of four contemporary risk stratification schemes to predict thromboembolism in non-anticoagulated patients with atrial fibrillation. Int J Cardiol. 2013; 166(1): 205–209.
  2. Banecka-Majkutewicz Z, Nyka W, Krzesniak-Bohdan M, et al. Analiza czynników ryzyka udaru niedokrwiennego mózgu (badanie wstępne). Udar Mózgu. 2002; 4: 15–22.
  3. Camm AJ, Kirchhof P, Lip GYH. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace . 2010; 12(10): 1360–1420.
  4. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37(38): 2893–2962.
  5. Gladstone DJ, Dorian P, Spring M, et al. EMBRACE Steering Committee and Investigators, EMBRACE Investigators and Coordinators. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014; 370(26): 2467–2477.
  6. Hobbs FDR, Fitzmaurice DA, Mant J, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess. 2005; 9(40): iii–iv, ix.
  7. Lin HJ, Wolf PA, Kelly-Hayes M, et al. Stroke severity in atrial fibrillation: the Framingham Study. Stroke. 1996; 27(10): 1760–1764.
  8. Jorgensen HS, Nakayama H, Reith J, et al. Acute stroke with atrial fibrillation: the Copenhagen Stroke Study. Stroke. 1996; 27(10): 1765–1769.
  9. Czlonkowska A, Ryglewicz D, Weissbein T, et al. A prospective community-based study of stroke in Warsaw, Poland. Stroke. 1994; 25(3): 547–551.
  10. Pierzchała K, Łabuz-Roszak B, et al. Analiza czynników ryzyka chorób naczyniowych mózgu u chorych leczonych w Pododdziale Udarowym. Wiad Lek. 2006; 63: 1–2.
  11. Staszewski J. Atrial fibrillation characteristics in patients with ischaemic stroke. Kardiol Pol. 2007; 65(7): 751–7; discussion 758.
  12. Palm F, Urbanek C, Wolf J, et al. Etiology, risk factors and sex differences in ischemic stroke in the Ludwigshafen Stroke Study, a population-based stroke registry. Cerebrovasc Dis. 2012; 33(1): 69–75.
  13. Buchwald F, Norrving Bo, Petersson J. Atrial fibrillation in transient ischemic attack versus ischemic stroke: a Swedish Stroke Register (Riksstroke) Study. Stroke. 2016; 47(10): 2456–2461.
  14. Olesen JB, Lip GYH, Lindhardsen J, et al. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study. Thromb Haemost. 2011; 106(4): 739–749.
  15. Maliszewska M. Czynniki ryzyka wystapienia udarów niedokrwiennych mózgu. Przew Lek. 2009; 7: 7–12.
  16. Olesen JB, Fauchier L, Lane DA, et al. Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. Chest. 2012; 141(1): 147–153.
  17. Moerch-Rasmussen A, Nacu A, Waje-Andreassen U, et al. Recurrent ischemic stroke is associated with the burden of risk factors. Acta Neurol Scand. 2016; 133(4): 289–294.
  18. Lehtola H, Airaksinen KEJ, Hartikainen P, et al. Stroke recurrence in patients with atrial fibrillation: concomitant carotid artery stenosis doubles the risk. Eur J Neurol. 2017; 24(5): 719–725.
  19. Gurański K, Podemski R, Ejma M. Ukrwotocznione zawały mózgu. Udar Mózgu. 2001; 3: 77–84.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl